Lindquist S G, Holm I E, Schwartz M, Law I, Stokholm J, Batbayli M, Waldemar G, Nielsen J E
Memory Disorders Research Group, The Neuroscience Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Eur J Neurol. 2008 Apr;15(4):377-85. doi: 10.1111/j.1468-1331.2008.02069.x. Epub 2008 Feb 16.
We report clinical, molecular, neuroimaging and neuropathological features of a Danish family with autosomal dominant inherited dementia, a clinical phenotype resembling Alzheimer's disease and a pathogenic mutation (R406W) in the microtubule associated protein tau (MAPT) gene. Pre-symptomatic and affected family members underwent multidisciplinary (clinical, molecular, neuroimaging and neuropathological) examinations. Treatment with memantine in a family member with early symptoms, based on the clinical phenotype and the lack of specific treatment, appears to stabilize the disease course and increase the glucose metabolism in cortical and subcortical areas, as determined by serial [F(18)]FDG-PET scanning before and after initiation of treatment. Neuropathological examination of a second affected and mutation-positive family member showed moderate atrophy of the temporal lobes including the hippocampi. Microscopy revealed abundant numbers of tau-positive neurofibrillary tangles in all cortical areas and in some brainstem nuclei corresponding to a diagnosis of frontotemporal lobe degeneration on the basis of a MAPT mutation. The clinical and genetic heterogeneity of autosomal dominant inherited dementia must be taken into account in the genetic counselling and genetic testing of families with autosomal dominantly inherited dementia in general.
我们报告了一个丹麦家族的临床、分子、神经影像学和神经病理学特征,该家族患有常染色体显性遗传痴呆症,其临床表型类似于阿尔茨海默病,且微管相关蛋白tau(MAPT)基因存在致病突变(R406W)。症状前和患病的家族成员接受了多学科(临床、分子、神经影像学和神经病理学)检查。基于临床表型且缺乏特异性治疗方法,对一名有早期症状的家族成员使用美金刚进行治疗,似乎稳定了病程,并增加了皮质和皮质下区域的葡萄糖代谢,这是通过治疗开始前后的系列[F(18)]FDG-PET扫描确定的。对另一名患病且突变阳性的家族成员进行的神经病理学检查显示,包括海马体在内的颞叶出现中度萎缩。显微镜检查发现所有皮质区域和一些脑干核中有大量tau阳性神经原纤维缠结,基于MAPT突变,这符合额颞叶变性的诊断。在对一般常染色体显性遗传痴呆症家族进行遗传咨询和基因检测时,必须考虑到常染色体显性遗传痴呆症的临床和遗传异质性。